Your browser doesn't support javascript.
loading
Proposed diagnostic criteria and classification of basophilic leukemias and related disorders.
Valent, P; Sotlar, K; Blatt, K; Hartmann, K; Reiter, A; Sadovnik, I; Sperr, W R; Bettelheim, P; Akin, C; Bauer, K; George, T I; Hadzijusufovic, E; Wolf, D; Gotlib, J; Mahon, F-X; Metcalfe, D D; Horny, H-P; Arock, M.
Afiliação
  • Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Sotlar K; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Blatt K; Institute of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Hartmann K; Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Reiter A; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Sadovnik I; Department of Dermatology, University of Luebeck, Luebeck, Germany.
  • Sperr WR; Department of Hematology and Oncology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
  • Bettelheim P; Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Akin C; Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Bauer K; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • George TI; Division of Laboratory Medicine, Elisabethinen Hospital Linz, Linz, Austria.
  • Hadzijusufovic E; Division of Rheumatology, Immunology and Allergy, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
  • Wolf D; Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Gotlib J; Department of Pathology, University of New Mexico, Albuquerque, NM, USA.
  • Mahon FX; Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Metcalfe DD; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • Horny HP; Medical Clinic III for Oncology, Haematology and Rheumatology, University Hospital Bonn, Bonn, Germany.
  • Arock M; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Leukemia ; 31(4): 788-797, 2017 04.
Article em En | MEDLINE | ID: mdl-28090091
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Basófilos / Leucemia Basofílica Aguda / Leucemia Mielogênica Crônica BCR-ABL Positiva / Transtornos Leucocíticos Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Basófilos / Leucemia Basofílica Aguda / Leucemia Mielogênica Crônica BCR-ABL Positiva / Transtornos Leucocíticos Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Áustria